GLP-1 Weight Management Drugs Drive Up Employer Healthcare Expenses, According to Gallagher ReBy insurancejournalnewsMarch 21, 20250 Gallagher Re’s analysis examines the financial impact of GLP-1 weight management drugs like Ozempic, Wegovy, and Mounjaro on employer-sponsored health plans, considering both rising prescription costs and potential health outcome improvements.
